Charles River Labs execs discuss AI's role in drug discovery and clinical development in Technology Networks.

{
  "signal_id": "ccf32fd7-e84b-4592-832b-7d78b6bc47e1",
  "signal_type": "linkedin-post-company",
  "signal_subtype": "linkedinPost",
  "detected_at": "2026-08-13T16:41:35.088+00:00",
  "company": {
    "name": "Charles River Laboratories",
    "domain": "criver.com"
  },
  "data": {
    "tags": [
      "Artificial Intelligence",
      "Product Development",
      "Research & Development"
    ],
    "summary": "Charles River Labs execs discuss AI's role in drug discovery and clinical development in Technology Networks.",
    "post_url": "https://www.linkedin.com/posts/charles-river-laboratories_where-ai-fits-in-the-future-of-drug-development-activity-7492674931005050880-pACB",
    "num_likes": 1,
    "post_text": "Steven Bulera, Chief Scientific Officer, Discovery and Safety Assessment, and Laura Lotfi, Director, Digital Product Management, Scientific Innovation, and Global Technology Solutions, were featured in Technology Networks, where they explored the evolving role of AI across #drugdiscovery, preclinical research, and clinical development. \n\nThey discussed how AI can enhance operational efficiency, support innovations such as Virtual Control Groups (VCGs), and improve decision-making throughout the development process. They also emphasized that scientific expertise, high-quality data, and rigorous testing remain essential to bringing safe and effective therapies to patients.\n\nRead more here: https://okt.to/hogta6",
    "initiatives": [
      {
        "topic": "enhancing operational efficiency with AI",
        "urgency": 0.6
      },
      {
        "topic": "supporting innovations like Virtual Control Groups",
        "urgency": 0.5
      },
      {
        "topic": "improving decision-making in drug development",
        "urgency": 0.6
      }
    ],
    "posted_date": "2026-08-10T20:15:10.720Z",
    "num_comments": 1,
    "technologies_mentioned": [
      {
        "name": "AI",
        "status": "using"
      }
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/ccf32fd7-e84b-4592-832b-7d78b6bc47e1 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"crl.com","limit":20}'